Free Trial
NASDAQ:MGTX

MeiraGTx (MGTX) Stock Price, News & Analysis

MeiraGTx logo
$8.89 +0.42 (+4.96%)
Closing price 04:00 PM Eastern
Extended Trading
$8.88 -0.01 (-0.06%)
As of 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MeiraGTx Stock (NASDAQ:MGTX)

Key Stats

Today's Range
$8.38
$8.92
50-Day Range
$4.64
$8.62
52-Week Range
$3.85
$8.92
Volume
626,369 shs
Average Volume
406,584 shs
Market Capitalization
$714.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.00
Consensus Rating
Buy

Company Overview

MeiraGTx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
85th Percentile Overall Score

MGTX MarketRank™: 

MeiraGTx scored higher than 85% of companies evaluated by MarketBeat, and ranked 158th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MeiraGTx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MeiraGTx has only been the subject of 1 research reports in the past 90 days.

  • Read more about MeiraGTx's stock forecast and price target.
  • Earnings Growth

    Earnings for MeiraGTx are expected to grow in the coming year, from ($1.48) to $0.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MeiraGTx is -3.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MeiraGTx is -3.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MeiraGTx has a P/B Ratio of 10.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MeiraGTx's valuation and earnings.
  • Percentage of Shares Shorted

    5.02% of the float of MeiraGTx has been sold short.
  • Short Interest Ratio / Days to Cover

    MeiraGTx has a short interest ratio ("days to cover") of 6.5.
  • Change versus previous month

    Short interest in MeiraGTx has recently increased by 1.63%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    MeiraGTx does not currently pay a dividend.

  • Dividend Growth

    MeiraGTx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.02% of the float of MeiraGTx has been sold short.
  • Short Interest Ratio / Days to Cover

    MeiraGTx has a short interest ratio ("days to cover") of 6.5.
  • Change versus previous month

    Short interest in MeiraGTx has recently increased by 1.63%, indicating that investor sentiment is decreasing.
  • News Sentiment

    MeiraGTx has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for MeiraGTx this week, compared to 2 articles on an average week.
  • Search Interest

    7 people have searched for MGTX on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added MeiraGTx to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MeiraGTx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $522,575.00 in company stock.

  • Percentage Held by Insiders

    Only 7.50% of the stock of MeiraGTx is held by insiders.

  • Percentage Held by Institutions

    67.48% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MeiraGTx's insider trading history.
Receive MGTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter.

MGTX Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
MeiraGTx Holdings plc (MGTX) - Yahoo Finance
See More Headlines

MGTX Stock Analysis - Frequently Asked Questions

MeiraGTx's stock was trading at $6.09 at the beginning of the year. Since then, MGTX shares have increased by 46.0% and is now trading at $8.89.

MeiraGTx Holdings PLC (NASDAQ:MGTX) released its earnings results on Tuesday, May, 13th. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.38) by $0.13. The company earned $1.93 million during the quarter, compared to the consensus estimate of $4.44 million. MeiraGTx had a negative trailing twelve-month return on equity of 241.05% and a negative net margin of 484.90%.

MeiraGTx (MGTX) raised $75 million in an initial public offering on Friday, June 8th 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI acted as the underwriters for the IPO and Chardan was co-manager.

Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MeiraGTx investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Moderna (MRNA).

Company Calendar

Last Earnings
5/13/2025
Today
7/14/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MGTX
CIK
1735438
Fax
N/A
Employees
300
Year Founded
N/A

Price Target and Rating

High Price Target
$35.00
Low Price Target
$13.00
Potential Upside/Downside
+183.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$147.79 million
Net Margins
-484.90%
Pretax Margin
-484.90%
Return on Equity
-241.05%
Return on Assets
-62.93%

Debt

Debt-to-Equity Ratio
2.34
Current Ratio
1.53
Quick Ratio
1.51

Sales & Book Value

Annual Sales
$33.28 million
Price / Sales
20.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.87 per share
Price / Book
9.74

Miscellaneous

Outstanding Shares
80,360,000
Free Float
74,338,000
Market Cap
$680.65 million
Optionable
Optionable
Beta
1.24
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:MGTX) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners